PIK3CA and breast carcinoma: On the other hand, the PIK3CA mutation in SSC, apart from its utility in molecularly defining the precise tumor type, could also be used as a molecular target as has been seen in another solid tumor such as in breast cancer and its associated guided-therapy alpelisib plus fulvestrant [55].